Detalhe da pesquisa
1.
Influence of microbiota-associated metabolic reprogramming on clinical outcome in patients with melanoma from the randomized adjuvant dendritic cell-based MIND-DC trial.
Nat Commun
; 15(1): 1633, 2024 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38395948